| Net Cash Provided by (Used in) Operating Activities |
-1.39M |
USD |
+23.6% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
840K |
USD |
-77.7% |
Q1 2023 |
Q1 2024 |
| Common Stock, Shares Authorized |
230M |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Common Stock, Shares, Issued |
136M |
shares |
+0.07% |
Q2 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-786K |
USD |
-139% |
Q1 2023 |
Q1 2023 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.9M |
USD |
-70% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Valuation Allowance |
40.3M |
USD |
+6.82% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
34.6M |
USD |
+7.41% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
2M |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Unrecognized Tax Benefits |
0 |
USD |
|
Q2 2025 |
Q2 2025 |
| Additional Paid in Capital |
111M |
USD |
+1.29% |
Q2 2025 |
Q2 2025 |
| Depreciation, Depletion and Amortization |
9.61K |
USD |
-10.3% |
Q1 2023 |
Q1 2023 |
| Share-based Payment Arrangement, Expense |
1.41M |
USD |
-20.2% |
Q2 2025 |
Q2 2025 |
| Interest Expense |
1.01M |
USD |
-0.67% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |